Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.8008 (2.13%) ($5.7600 - $5.9832) on Wed. May. 29, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.84% (three month average) | RSI | 33 | Latest Price | $5.8008(2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -2.5% a day on average for past five trading days. | Weekly Trend | EYES declines -12.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UNG(6%) FIVG(5%) ICLN(5%) IFRA(5%) | Factors Impacting EYES price | EYES will decline at least -2.92% in a week (0% probabilities). BND(-8%) VCIT(-6%) LQD(-6%) XLP(-5%) TIP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.92% (StdDev 5.84%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
1 - 5 Day Possible Target | $-14.99(-358.41%) | Resistance Level | $7.13 | 5 Day Moving Average | $5.96(-2.67%) | 10 Day Moving Average | $6.47(-10.34%) | 20 Day Moving Average | $7.13(-18.64%) | To recent high | -36.4% | To recent low | 2.2% | Market Cap | $1.853b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |